U.S.: New DEA Rule Bans CBD
Update 12/16/2016: Although widely reported by many news sources that the DEA has banned cannabidiol (CBD), the Hemp Industry Association has made it clear that the DEA has, in fact, not banned CBD.
By Derrick Stanley
The U.S. Drug Enforcement Administration (DEA) just banned cannabidiol (CBD), placing it on its list of Schedule 1 drugs. CBD is a chemical found in marijuana that won't make you high, but will stop seizures and help people with debilitating conditions.
Schedule 1 drugs are considered to have no medical benefit and to be highly addictive. The DEA banned the herbal pain reliever Kratom earlier this year, another alternative to dangerous prescription opioids.
DEA Acting Administrator Chuck Rosenberg said this code “will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana.”
The rule reads, “For practical purposes, all extracts that contain CBD will also contain at least small amounts of other cannabinoids. However, if it were possible to produce from the cannabis plant an extract that contained only CBD and no other cannabinoids, such an extract would fall within the new drug code.”
CBD derived from industrial hemp was being sold across the U.S. as if it was legal. The DEA said the new rule is to make sure the U.S. is complying with international drug-control treaties. So it now doesn't matter whether CBD is extracted from a marijuana plant or industrial hemp; it's all federally illegal.
The DEA's views on CBD and cannabis are as out of touch as their use of the word "marihuana". Petitioning led to an end to the ban on Kratom earlier this year. Maybe the DEA will listen if enough people speak up about the ridiculous CBD ban.